Sage Therapeutics logo

Sage Therapeutics Share Price Today

(NASDAQ: SAGE)

Sage Therapeutics share price is $7.55 & ₹656.62 as on 6 Mar 2025, 2.30 'hrs' IST

$7.55

0.23

(3.14%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Sage Therapeutics share price in Dollar and Rupees. Guide to invest in Sage Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Sage Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Sage Therapeutics share price movements

  • Today's Low: $7.31
    Today's High: $7.55

    Day's Volatility :3.25%

  • 52 Weeks Low: $4.62
    52 Weeks High: $22.34

    52 Weeks Volatility :79.32%

Sage Therapeutics (SAGE) Returns

PeriodSage Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
34.82%
3.7%
0.0%
6 Months
-1.18%
-2.8%
0.0%
1 Year
-64.27%
2.5%
0.0%
3 Years
-76.93%
12.9%
-11.6%

Sage Therapeutics (SAGE) Key Statistics

in dollars & INR

Previous Close
$7.32
Open
$7.16
Today's High
$7.55
Today's Low
$7.305
Market Capitalization
$450.0M
Today's Volume
$2.1M
52 Week High
$22.34
52 Week Low
$4.62
Revenue TTM
$41.2M
EBITDA
$-409.5M
Earnings Per Share (EPS)
$-6.7
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-63.37%

How to invest in Sage Therapeutics Stock (SAGE) from India?

It is very easy for Indian residents to invest directly in Sage Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sage Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sage Therapeutics or SAGE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sage Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sage Therapeutics shares which would translate to 0.115 fractional shares of Sage Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Sage Therapeutics, in just a few clicks!

Returns in Sage Therapeutics (SAGE) for Indian investors in Rupees

The Sage Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sage Therapeutics investment value today

Current value as on today

₹40,680

Returns

₹59,320

(-59.32%)

Returns from Sage Therapeutics Stock

₹64,269 (-64.27%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Sage Therapeutics (SAGE)

-73%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Sage Therapeutics Stock from India on INDmoney has decreased by -73% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Sage Therapeutics

  • BlackRock Inc

    7.89%

  • Vanguard Group Inc

    7.87%

  • Morgan Stanley - Brokerage Accounts

    7.47%

  • Bellevue Group AG

    7.26%

  • FMR Inc

    6.70%

  • Caligan Partners LP

    4.97%

Analyst Recommendation on Sage Therapeutics

Hold

    33%Buy

    62%Hold

    3%Sell

Based on 27 Wall street analysts offering stock ratings for Sage Therapeutics(by analysts ranked 0 to 5 stars)

Based on 27 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
17
19
19
Sell
1
0
0

Analyst Forecast on Sage Therapeutics Stock (SAGE)

What analysts predicted

Upside of 8.94%

Target:

$8.23

Current:

$7.55

Insights on Sage Therapeutics Stock (Ticker Symbol: SAGE)

  • Price Movement

    In the last 7 days, SAGE stock has moved up by 5.0%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 7.90M → 12.81M (in $), with an average increase of 14.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -93.55M → -95.77M (in $), with an average decrease of 2.4% per quarter
  • SAGE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 130.8%
  • SAGE vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 129.3%
  • Price to Sales

    ForSAGE every $1 of sales, investors are willing to pay $11.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Sage Therapeutics Technicals Summary

Sell

Neutral

Buy

Sage Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Sage Therapeutics (SAGE) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Sage Therapeutics Inc logo
4.28%
-1.18%
-64.27%
-76.93%
-83.15%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Sage Therapeutics Inc logo
NA
NA
0.74
-3.72
-0.63
-0.36
NA
7.58
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Sage Therapeutics Inc logo
Hold
$450.0M
-83.15%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Sage Therapeutics

Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes brain health medicines. The company offers ZURZUVAE, a neuroactive steroid positive allosteric modulator of GABA receptors targeting synaptic and extrasynaptic GABA receptors for the treatment of postpartum depression in adults. Its product pipeline also includes SAGE-324, a novel GABA receptor positive allosteric modulator for chronic oral dosing, including seizures in developmental and epileptic encephalopathies; and SAGE-319, an extrasynaptic-preferring GABA receptor positive allosteric modulator PAM for treating behavioral symptoms associated with neurodevelopmental disorders. In addition, the company is developing various product candidates, including SAGE-817 and SAGE-039 for the treatment of acute and chronic brain health disorders, including work on allosteric modulation of the GABA and NMDA receptor systems in the brain, as well as NMDA receptor negative allosteric modulator focusing on the treatments for neurodevelopmental disorders. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
Organization
Sage Therapeutics
Employees
353
CEO
Mr. Barry E. Greene
Industry
Health Technology

Management People of Sage Therapeutics

NameTitle
Mr. Barry E. Greene
President, CEO & Director
Mr. Christopher Benecchi
Chief Operating Officer
Dr. Laura Gault M.D., Ph.D.
Chief Medical Officer
Mr. Mike Quirk Ph.D.
Chief Scientific Officer
Ashley Kaplowitz
Director of Investor Relations
Mr. Gregory Shiferman
Senior VP & General Counsel
Ms. Pamela Herbster
VP & Head of People
Dr. Helen Colquhoun
Senior Vice President of Drug Safety & Pharmacovigilance
Ms. Vanessa Procter
Senior Vice President of Corporate Affairs
Dr. Aaron Koenig M.D.
Medical Director of Early Clinical Development

Important FAQs about investing in SAGE Stock from India :

What is Sage Therapeutics share price today?

Sage Therapeutics share price today stands at $7.55, Open: $7.16 ; Previous Close: $7.32 ; High: $7.55 ; Low: $7.31 ; 52 Week High: $22.34 ; 52 Week Low: $4.62.

The stock opens at $7.16, after a previous close of $7.32. The stock reached a daily high of $7.55 and a low of $7.31, with a 52-week high of $22.34 and a 52-week low of $4.62.

Can Indians buy Sage Therapeutics shares?

Yes, Indians can invest in the Sage Therapeutics (SAGE) from India.

With INDmoney, you can buy Sage Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Sage Therapeutics at zero transaction cost.

How can I buy Sage Therapeutics shares from India?

It is very easy to buy Sage Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sage Therapeutics (SAGE) be purchased?

Yes, you can buy fractional shares of Sage Therapeutics with INDmoney app.

What are the documents required to start investing in Sage Therapeutics stocks?

To start investing in Sage Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Sage Therapeutics Stock (SAGE)?

Today’s highest price of Sage Therapeutics (SAGE) is $7.55.

Today’s lowest price of Sage Therapeutics (SAGE) is $7.31.

What is today's market capitalisation of Sage Therapeutics?

Today's market capitalisation of Sage Therapeutics SAGE is 450.0M

What is the 52 Week High and Low Range of Sage Therapeutics Stock (SAGE)?

  • 52 Week High

    $22.34

  • 52 Week Low

    $4.62

What are the historical returns of Sage Therapeutics (SAGE)?

  • 1 Month Returns

    4.28%

  • 3 Months Returns

    -1.18%

  • 1 Year Returns

    -64.27%

  • 5 Years Returns

    -83.15%

Who is the Chief Executive Officer (CEO) of Sage Therapeutics ?

Mr. Barry E. Greene is the current Chief Executive Officer (CEO) of Sage Therapeutics.